Business Description
Ampio Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US03209T1097
Description
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the clinical development of Ampion and preclinical development. Its product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19-induced respiratory distress.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 15.52 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 13.5 | |||||
| 3-Year EPS without NRI Growth Rate | 11.2 | |||||
| 3-Year FCF Growth Rate | 7.4 | |||||
| 3-Year Book Growth Rate | 8.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.2 | |||||
| 9-Day RSI | 38.2 | |||||
| 14-Day RSI | 41.4 | |||||
| 6-1 Month Momentum % | -9.58 | |||||
| 12-1 Month Momentum % | -77.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.67 | |||||
| Quick Ratio | 3.67 | |||||
| Cash Ratio | 2.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.6 | |||||
| Shareholder Yield % | 8.95 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -116.17 | |||||
| ROA % | -87.9 | |||||
| ROIC % | -1318.42 | |||||
| ROC (Joel Greenblatt) % | -1684.42 | |||||
| ROCE % | -111.64 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.42 | |||||
| Price-to-Tangible-Book | 0.42 | |||||
| EV-to-EBIT | 0.26 | |||||
| EV-to-EBITDA | 0.28 | |||||
| EV-to-FCF | 0.24 | |||||
| Price-to-Net-Current-Asset-Value | 0.42 | |||||
| Price-to-Net-Cash | 0.64 | |||||
| Earnings Yield (Greenblatt) % | 384.62 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:AMPE
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ampio Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -20.6 | ||
| Beta | 1.38 | ||
| Volatility % | 85.62 | ||
| 14-Day RSI | 41.4 | ||
| 14-Day ATR ($) | 0.383166 | ||
| 20-Day SMA ($) | 4.11005 | ||
| 12-1 Month Momentum % | -77.16 | ||
| 52-Week Range ($) | 3.354 - 13.2 | ||
| Shares Outstanding (Mil) | 0.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ampio Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ampio Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ampio Pharmaceuticals Inc Frequently Asked Questions
What is Ampio Pharmaceuticals Inc(AMPE)'s stock price today?
The current price of AMPE is $3.68. The 52 week high of AMPE is $13.20 and 52 week low is $3.35.
When is next earnings date of Ampio Pharmaceuticals Inc(AMPE)?
The next earnings date of Ampio Pharmaceuticals Inc(AMPE) is 2023-11-10 Est..
Does Ampio Pharmaceuticals Inc(AMPE) pay dividends? If so, how much?
Ampio Pharmaceuticals Inc(AMPE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers